Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid

Detalles Bibliográficos
Autores principales: Zachariah, U., Nair, S.C., Goel, A., Balasubramanian, K.A., Mackie, I., Elias, E., Eapen, C.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198395/
https://www.ncbi.nlm.nih.gov/pubmed/32403033
http://dx.doi.org/10.1016/j.thromres.2020.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198395/
https://www.ncbi.nlm.nih.gov/pubmed/32403033
http://dx.doi.org/10.1016/j.thromres.2020.05.001

Ejemplares similares